Analysis of expression and function of the costimulatory molecule 4-1BB in alloimmune responses

Transplantation

Volumn 70, Issue 1, 2000, Pages 175-183

  Tan, Joyce T ^a   Ha, Jongwon ^a   Cho, Hong Rae ^b   Tucker Burden, Carol ^a   Hendrix, Rose C ^a   Mittler, Robert S ^c   Pearson, Thomas C ^a   Larsen, Christian P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD137; CYTOKINES; HEART TRANSPLANTATION; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034662209     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Schwartz RH. Acquisition of immunologie self-tolerance. Cell 1989; 57: 1073.
2. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71 (7): 1065.
3. Whitmire JK, Slifka MK, Grewal IS, Flavell RA, Ahmed R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection [published erratum appears in J Virol 1997 Feb;71 (2):1736]. J Virol. 1996; 70 (12): 8375.
4. Shahinian A, Pfeffer K, Lee KP, et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261 (5121): 609.
5. Lenschow DJ, Walunas TL, Blueston JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
6. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111.
7. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
8. + T cells play a critical role in costimulation blockade resistant allograft rejection. J Clin Invest 1999; 104(12): 1715.
9. Kwon BS, Weissman SM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 1989; 86(6): 1963.
10. Crispe IN. Fatal interactions: fas-induced apoptosis of mature T-cells. Immunity 1994; 1: 347.
11. Wong B, Choi Y. Pathways leading to cell death in T cells. Curr Opinion Immunol 1997; 9 (3): 358.
12. Chiarle R, Podda A, Prolla G, Podack ER, Thorbecke GJ, Inghirami G. CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway. J Immunol 1999; 163 (1): 194.
13. Kurts C, Carbone FR, Krummel MF, Koch KM, Miller JF, Heath WR. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 1999; 398 (6725): 341.
14. Akiba H, Oshima H, Takeda K, et al. CD28-independent co-stimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol 1999; 162 (12): 7058.
15. Weinberg AD, Vella AT, Croft M. OX-40: life beyond the effector T cell stage. Semin Immunol 1998; 10 (6): 471.
16. Gramaglia I, Weinberg AD, Lemon M, Croft M. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 1998; 161 (12): 6510.
17. Stuber E, Neurath M, Calderhead D, Fell HP, Strober W. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995; 2 (5): 507.
18. Stuber E, Strober W. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp. Med 1996; 183 (3): 979.
19. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 1996; 14: 591.
20. Pollok KE, Kim YJ, Zhou Z, et al. Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol 1993; 150 (3): 771
21. Goodwin RG, Din WS, Davis-Smith T, et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur J Immunol 1993; 23 (10): 2631.
22. DeBenedette MA, Shahinian A, Mak TW, Watts TH. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J Immunol 1997; 158 (2): 551.
23. DeBenedette MA, Chu NR, Pollok KE, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995; 181 (3): 985.
24. Hurtado JeC, Kim SH, Pollok KE, Lee ZH, Kwon BS. Potential role of 4-1BB in Tcell activation: Comparison with costimulatory molecule CD28. J Immunol 1995; 155 (7): 3360.
25. Saoulli K, Lee SY, Cannons JL, et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp. Med 1998; 187 (11): 1849.
26. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell re+ sponses. J Exp. Med 1997; 186: 47.
27. Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nature Med 1997; 3 (6): 682.
28. Takahashi C, Mittler RS, Vella AT. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol 1999; 162 (9): 5037.
29. Alderson MR, Smith CA, Tough TW, et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J Immunol 1994; 24 (9): 2219.
30. Pollok KE, Kim YJ, Hurtado J, Zhou Z, Kim KK, Kwon BS. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol 1994; 242): 367.
31. Chalupny NJ, Peach R, Hollenbaugh D, Ledbetter JA, Farr AG, Aruffo A. T-cell activation molecule 4-1BB binds to extracellular matrix proteins. Proc Natl Acad Sci USA 1992; 89 (21): 10360.
32. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 1996; 61 (1): 4.
33. Larsen CP, Ritchie SC, Hendrix R, et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152 (11): 5208.
34. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992; 176: 1215.
35. Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171 (1): 131.
36. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Selective Expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 1988; 335: 271.
37. Arch RH, Thompson CB. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor sub-family that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol 1998; 18 (1): 558.
38. Kim YJ, Pollok KE, Zhou Z, et al. Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p561ck1. J Immunol 1993; 151 (3): 1255.
39. Anderson SJ, Levin SD, Perlmutter RM. Involvement of the protein tyrosine kinase p561ck in T cell signaling and thymocyte development. Adv Immunol 1994; 56: 151.
40. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259 (5102): 1739.
41. Melero I, Bach N, Hellstrom KE, Aruffo A, Mittler RS, Chen L. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway. Eur. J Immunol 1998; 28 (3): 1116.
42. Guinn BA, DeBenedette MA, Watts TH, Berinstein NL. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J Immunol 1999; 162 (8): 5003.
43. Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 4-1BB Ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 1999; 163: 4859.
44. DeBenedette MA, Wen T, Bachmann MF, et al. Analysis of 4-1BB Ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 1999; 163: 4833.